• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Varian

Varian

  1. All
  2. Morningstar Articles
  3. Investing
  1. Greece’s Darkest Hour Before Its Dawn

    Varian Medical Systems' VAR third-quarter results were in line with our expectations, and we are leaving our fair value estimate unchanged. Overall, revenue increased 7%, and net orders rose 13%, bringing the company's backlog at quarter-end to $1.6 billion. Revenue for the oncology system segment ...

  2. Research Roundup: Foreign Diversification, Social Comparisons and Consumer Identity

    Varian Medical's VAR third-quarter fiscal 2006 results fall right in line with the seasonal patterns we expected from our current near-term modeling assumptions. The oncology group notched 14% growth, and customer demand continues to reflect a shift toward Varian's next-generation IGRT technology, ...

  3. Health Care: A Few Stocks Still Offer Upside

    Despite the sector looking slightly overvalued, we still see stocks with attractive valuations across the different industries.

  4. Health Care: 3 Picks in a More Expensive Sector

    Despite the sector looking slightly overvalued overall, we still see stocks that offer attractive valuations across the different industries.

  5. Health Care: A Strong Run, but Some Stocks Still Look Undervalued

    While the sector looks slightly overvalued overall, we still see several stocks that offer attractive valuations across the different industries.

  6. A Deeper Look at the Applied Materials-Tokyo Electron Merger

    The combination makes plenty of sense and should better position the firm for the future.

  7. Safe Stocks for Worried Investors

    The stocks mentioned in this article be holdings in the managed portfolios of Validea Capital Management, a separate asset management firm founded by Validea.com founder John Reese. Validea Capital Management, which an SEC registered investment advisory firm and a separate company from Validea.com, ...

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.